Highlights
Nature: Meet ‘goldene’: this gilded cousin of graphene is also one atom thick
18 April 2024Sheets of gold might find use as catalysts, or in light-sensing devices.
C&EN: Mechanochemistry strips cargo molecules from a loaded rotaxane
13 April 2024Using polymer strands to pull a ring along an axle could release repair molecules in self-healing materials.
C&EN: Machine learning improves beer flavor
27 March 2024Algorithm correlates online reviews with chemical profiles of hundreds of beers, providing a roadmap to enhance taste.
C&EN: Scorching heat turns MOF into discerning hydrogenation catalyst
20 March 2024By selectively turning alkynes into alkenes, the porous material could pave the way for more efficient purification of polymer feedstocks.
C&EN: Photochemistry unleashes a one-two radical punch for efficient ring synthesis
20 March 2024Iridium and nickel catalysts cooperate to install nonaromatic rings in drug molecules.
TESTIMONIALS
“As an editor and reporter, Mark Peplow is fast, accurate, and versatile. He covers science policy and pure research with equal passion, and his writing combines a scientist’s precision with a journalist’s verve.” Tim Appenzeller
Former Chief Magazine Editor at Nature, now News Editor at Science
"Mark guided me through some of the most challenging stories I've written. These are pieces I might not have attempted were it not for his steady editorial hand." Linda Nordling
Freelance Journalist, South Africa
“Working with Mark is never anything other than a pleasure. He is the kind of editor that writers hope for: able to identify what needs fixing and what doesn’t, bringing to bear a wealth of knowledge, always clear, prompt and easy to talk with. Much of that comes from being a splendid writer himself.”
Philip Ball
Freelance Science Writer
Author Archives: benbaxter
The Pharmaceutical Journal: FDA plays catch-up with Europe as it moves towards first biosimilar approval
The FDA has finally indicated it will approve the first biosimilar drug for the United States, years after Europe.
Posted in Highlights
Comments Off on The Pharmaceutical Journal: FDA plays catch-up with Europe as it moves towards first biosimilar approval
The Pharmaceutical Journal: Testosterone rollercoaster tackles prostate cancer
‘Bipolar androgen therapy’ helps patients with tumours that are resistant to conventional hormone treatments.
Posted in Highlights
Comments Off on The Pharmaceutical Journal: Testosterone rollercoaster tackles prostate cancer
